Has Nadia McFarlane received payments from drug or device companies?

Yes. Drug and device makers reported $19,823 in general payments to Nadia McFarlane across 115 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nadia McFarlane did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nadia McFarlane come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nadia McFarlane

Psychiatry · Katy, TXNPI 1619175239

Payments from drug & device makers

What this record shows

This record is dominated by other: $17,410 of the $19,823 with a category attached, or 87.8%. Neuronetics, Inc. accounts for 88.1% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $18,428, more than ten times the $48 reported in 2019. Among psychiatry clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,823in general payments, 2019–2025

Across 115 payments — averaging $172.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neuronetics, Inc.$17K
Corium, LLC$294
Takeda Pharmaceuticals U.S.A., Inc.$250
Supernus Pharmaceuticals, Inc.$246
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$177
Ironshore Pharmaceuticals Inc.$144
plus $1K from 17 others

What the payments were for

Food & beverage$2,41312%
Other$17,41088%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neuronetics, Inc.	4	$17,473
Corium, LLC	13	$294
Takeda Pharmaceuticals U.S.A., Inc.	13	$250
Supernus Pharmaceuticals, Inc.	14	$246
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	7	$177
Ironshore Pharmaceuticals Inc.	7	$144
Otsuka America Pharmaceutical, Inc.	5	$126
E.r. Squibb & Sons, L.L.C.	6	$120
Neos Therapeutics, LP	7	$119
Noven Therapeutics, LLC	6	$110
Axsome Therapeutics, Inc.	4	$108
Alkermes, Inc.	5	$94
Collegium Pharmaceutical, Inc.	4	$85
Johnson & Johnson	2	$76
Neurocrine Biosciences, Inc.	3	$75
Lundbeck LLC	3	$67
AbbVie	3	$52
Brainsway USA Inc	1	$51
Tris Pharma Inc	2	$44
Teva Pharmaceuticals USA, Inc.	2	$40
Vanda Pharmaceuticals Inc.	2	$29
Sunovion Pharmaceuticals Inc.	1	$26
Vertical Pharmaceuticals, LLC	1	$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

NEUROSTAR TMS THERAPY SYSTEM$17,410

How this compares

$19,823 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas →

Other psychiatry in Katy

Vikram MehraKaty$1.2M
Rakesh JainLake Jackson$7.2M
Arvinder Pal WaliaAustin$2.5M
Suresh SureddiPlano$2.2M
Martin GuerreroEl Paso$2M
Marty BennettAddison$1.8M
Matthew BramsHouston$1.5M
Joel HolinerDallas$948K
Frank ChenHouston$941K
Alice MaoHouston$850K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →